文献速递泌尿生殖介入腹部CT

多灶性肾细胞癌的经皮影像引导热消融:单中心10年经验

Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
PubMed 文献 · AJR Am J Roentgenol · 2017-07-05

回顾性分析23例经活检证实的多灶性肾细胞癌患者,采用CT引导经皮射频消融、冷冻消融或微波消融单次治疗,技术成功率为100%,49个肿瘤中41个(84%)达完全缓解,影像随访平均3.1年,局部无进展生存率96%(22/23),结论认为该治疗安全、有效且持久。

要点

  • 多灶性肾细胞癌单次CT引导热消融技术成功率达100%,完全缓解率84%(41/49个肿瘤)。
  • 影像随访平均3.1年,局部无进展生存率96%(22/23),肿瘤特异性无病生存率100%。
  • 49例次并发症中9例(18%)为Clavien-Dindo I级,未见更高级别并发症报告。

核心结论

  • CT引导经皮热消融是治疗多灶性肾肿块安全、有效且持久的干预措施。

研究设计与样本

  • 单中心回顾性分析,纳入23例经活检证实的多灶性肾细胞癌患者(16男7女,中位年龄70岁),采用CT引导经皮射频消融、冷冻消融或微波消融单次治疗,记录消融前后及随访血尿素氮、肌酐和估算肾小球滤过率以评估肾功能稳定性。

诊断标准与关键数值

  • 技术成功率100%;49个肿瘤中41个(84%)达完全缓解;影像随访(平均3.1年,范围0.1-9.6年)局部无进展生存率96%(22/23),肾细胞癌特异性无病生存率100%(23/23),总生存率91%(21/23);49例次并发症中9例(18%)为Clavien-Dindo I级;中位肿瘤大小2.3 cm(范围1.0-4.0 cm);平均RENAL肾测量评分6.3(范围4.0-10.0),平均PADUA评分7.8(范围6.0-11.0),平均中心性指数3.1(范围0.7-6.8);平均消融时间23分钟(范围3-24分钟)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of our study was to assess the technical success, safety, and oncologic and renal function outcomes of CT-guided percutaneous thermal ablation for synchronous multiple renal masses in a single session.

MATERIALS AND METHODS: A retrospective analysis of 23 patients (16 men and 7 women; median age, 70 years) with biopsy-proven multifocal renal cell carcinoma (RCC) masses treated with radiofrequency ablation (RFA), cryoablation, or microwave ablation (MWA) was performed. Preablation, postablation, and follow-up serum blood urea nitrogen, creatinine, and estimated glomerular filtration rate (GFR) levels were recorded to evaluate the stability of renal function. Technical success, complications, treatment response, oncologic outcome, and overall survival were assessed.

RESULTS: Biopsy-proven RCCs were treated in 23 patients. Median tumor size was 2.3 cm (range, 1.0-4.0 cm). The mean RENAL (radius, exophytic vs endophytic properties, nearness of tumor to the collecting system or sinus, anterior vs posterior, location relative to polar lines) nephrometry score was 6.3 (range, 4.0-10.0); mean PADUA (preoperative aspects and dimensions used for anatomical) score, 7.8 (range, 6.0-11.0); and mean centrality index (C-index), 3.1 (range, 0.7-6.8). The mean ablation time was 23 minutes (range, 3-24 minutes). Technical success was achieved for 100% of tumors. Of the 49 complications, nine (18%) were classified as Clavien-Dindo grade I complications. Complete response was achieved in 41 of the 49 (84%) tumors. Local progression-free, RCC-specific disease-free, and overall survival rates during the imaging follow-up time (mean, 3.1 years; range, 0.1-9.6 years) were 96% (22/23), 100% (23/23), and 91% (21/23), respectively.

CONCLUSION: CT-guided percutaneous thermal ablation is a safe, effective, and durable treatment intervention for multifocal renal masses.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Zhou W, Uppot RN, Feldman AS, et al. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center. AJR Am J Roentgenol. 2017. PMID: 28678572. doi:10.2214/AJR.17.18290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。